Inactive Instrument
Ocata Therapeutics Inc Share Price
Stocks
US67457L1008
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
John Heffernan
PRN | Corporate Officer/Principal | - | 02/02/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Toru Yoshimitsu
BRD | Director/Board Member | 63 | - |
Masaaki Hirano
BRD | Director/Board Member | 59 | - |
| Director/Board Member | 53 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.07% | +10.05% | +77.41% | +106.53% | 70.1B | |
| -0.87% | +0.08% | +36.96% | +65.04% | 54.93B | |
| -3.48% | -3.47% | +4.13% | +473.77% | 28.89B | |
| +0.04% | +12.56% | +54.67% | +5.47% | 23.9B | |
| -0.71% | +1.29% | -18.10% | -14.03% | 23.3B | |
| +0.35% | +8.24% | +252.94% | +466.50% | 18.41B | |
| -0.59% | +7.88% | +40.87% | -20.12% | 18.77B | |
| -0.57% | +6.85% | +30.20% | +580.70% | 16.1B | |
| +0.97% | -2.66% | +32.01% | +136.22% | 12.48B | |
| Average | -0.36% | +8.19% | +56.79% | +200.01% | 29.65B | |
| Weighted average by Cap. | -0.12% | +8.03% | +55.35% | +164.08% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
